Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FolateScan in metastatic renal cell carcinoma
NCT01689662Phase 2Completed
- Sponsor
- Endocyte
- Start
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etarfolatide in metastatic renal cell carcinoma (mRCC), sponsored by Endocyte. Started Aug 2002; status: completed.
02
Drugs
etarfolatide
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT01689662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01689662.